Live from the NIH registry
Studies recruiting near Birmingham right now
Top 25 of 969 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama (0.6 mi)
· Sponsor: American Society of Clinical Oncology
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AB Science
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Centers of Alabama — Homewood, Alabama (3.9 mi)
· Sponsor: Pacific Edge Limited
Radiation Free Study
Aortic Aneurysm
N/A
Interventional 182 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Flourish - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AbbVie
Process-Based Approach Case Series For Anxiety Problems
Anxiety
N/A
Interventional 10 participants sought
University of Alabama at Birmingham Dr. Borgogna's lab — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
University of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: New York Medical College
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Veterans Administration Medical Center - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: SWOG Cancer Research Network
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Bendcare, LLC — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 260 participants sought
UAB Comprehensive Cancer Center — Birmingham, Alabama (0.6 mi)
· Sponsor: Bristol-Myers Squibb
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 105 participants sought
University of Alabama At Birmingham Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: BeOne Medicines
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Annovis Bio Inc.
Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain
Knee Osteoarthritis
N/A
Interventional 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
Wavelength Intervention for Nearsighted Kids
Myopia
N/A
Interventional 80 participants sought
University of Alabama at Birmingham School of Optometry — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Jaeb Center for Health Research
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Birmingham, Alabama (0.6 mi)
· Sponsor: Sameek Roychowdhury
The ARISE Study - Use of Vertical Positioning
Acute Respiratory Distress Syndrome
N/A
Interventional 40 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Rheumatoid Arthritis, Systemic Lupus Erythematosus
Phase 1
Interventional 48 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
Phase 3
Interventional 2,000 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Uppsala University
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 178 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury
Spinal Cord Injuries, Transverse Myelitis
N/A
Interventional 60 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Systemic Lupus Erythematosus of Childhood (Disorder)
N/A
Interventional 175 participants sought
University of Alabama Birmingham Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: Michigan State University
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca